The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2
Open accessAbstract
Latent HIV proviruses are silenced as the result of deacetylation and methylation of histones located at the viral long terminal repeat (LTR). Inhibition of histone deacetylases (HDACs) leads to the reemergence of HIV-1 from latency, but the contribution of histone lysine methyltransferases (HKMTs) to maintaining HIV latency remains uncertain. Chromatin immunoprecipitation experiments using latently infected Jurkat T-cell lines demonstrated that the HKMT enhancer of Zeste 2 (EZH2) was present at high levels at the LTR of silenced HIV proviruses and was rapidly displaced following proviral reactivation. Knockdown of EZH2, a key component of the Polycomb repressive complex 2 (PRC2) silencing machinery, and the enzyme which is required for trimethyl histone lysine 27 (H3K27me3) synthesis induced up to 40% of the latent HIV proviruses. In contrast, there was less than 5% induction of latent proviruses following knockdown of SUV39H1, which is required for H3K9me3 synthesis. Knockdown of EZH2 also sensitized latent proviruses to external stimuli, such as T-cell receptor stimulation, and slowed the reversion of reactivated proviruses to latency. Similarly, cell populations that responded poorly to external stimuli carried HIV proviruses that were enriched in H3K27me3 and relatively depleted in H3K9me3. Treating latently infected cells with the HKMT inhibitor 3-deazaneplanocin A, which targets EZH2, led to the reactivation of silenced proviruses, whereas chaetocin and BIX01294 showed only minimal reactivation activities. These findings suggest that PRC2-mediated silencing is an important feature of HIV latency and that inhibitors of histone methylation may play a useful role in induction strategies designed to eradicate latent HIV pools.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
The Polycomb complex PRC2 and its mark in life
Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347
Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Tsai, M.-C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., Shi, Y., Segal, E., & Chang, H. Y. (2010) · Science · doi:10.1126/science.1192002 · Cited by 3,290 · cited 1×
“evidence that noncoding RNAs can help recruit PRC2 to target genes (33, 70).”
BackgroundIdentification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
Polycomb complexes repress developmental regulators in murine embryonic stem cells
Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., et al. (2006) · Nature · doi:10.1038/nature04733 · Cited by 2,514
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Chomont, N., El-Far, M., Ancuta, P., Trautmann, L., Procopio, F. A., Yassine-Diab, B., Boucher, G., Boulassel, M.-R., Ghattas, G., Brenchley, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1972 · Cited by 1,722
Siliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., Margolick, J. B., Kovacs, C., Gange, S. J., & Siliciano, R. F. (2003) · Nature Medicine · doi:10.1038/nm880 · Cited by 1,703
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596 · cited 1×
“The data presented here demonstrate that EZH2, the enzymatic component of PRC2 which is responsible for the formation of H3K27me3 (44), contributes to the establishment and maintenance of transcriptional silencing of HIV-1.”
BackgroundGenomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains
Ku, M., Koche, R. P., Rheinbay, E., Mendenhall, E. M., Endoh, M., Mikkelsen, T. S., Presser, A., Nusbaum, C., Xie, X., Chi, A. S., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000242 · Cited by 1,009
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro
Jordan, A., Bisgrove, D., & Verdin, E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg188 · Cited by 914
The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3
Cao, R., & Zhang, Y. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.02.001 · Cited by 914
Histone methylation in transcriptional control
Kouzarides, T. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00287-3 · Cited by 908
Davey, R. T., Bhat, N., Yoder, C., Chun, T.-W., Metcalf, J. A., Dewar, R., Natarajan, V., Lempicki, R. A., Adelsberger, J. W., Miller, K. D., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15109 · Cited by 849
Chun, T.-W., Engel, D., Berrey, M. M., Shea, T., Corey, L., & Fauci, A. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8869 · Cited by 846
The Challenge of Finding a Cure for HIV Infection
Richman, D. D., Margolis, D. M., Delaney, M., Greene, W. C., Hazuda, D., & Pomerantz, R. J. (2009) · Science · doi:10.1126/science.1165706 · Cited by 846
Self-citation7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes
Nguyen, V. T., Kiss, T., Michels, A. A., & Bensaude, O. (2001) · Nature · doi:10.1038/35104581 · Cited by 705
The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription
Yang, Z., Zhu, Q., Luo, K., & Zhou, Q. (2001) · Nature · doi:10.1038/35104575 · Cited by 681
DNA methylation and histone modifications: teaming up to silence genes
Fuks, F. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.08.002 · Cited by 644
Facultative Heterochromatin: Is There a Distinctive Molecular Signature?
Trojer, P., & Reinberg, D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.09.011 · Cited by 608
Miranda, T. B., Cortez, C. C., Yoo, C. B., Liang, G., Abe, M., Kelly, T. K., Marquez, V. E., & Jones, P. A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0013 · Cited by 596
JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells
Pasini, D., Cloos, P. A. C., Walfridsson, J., Olsson, L., Bukowski, J.-P., Johansen, J. V., Bak, M., Tommerup, N., Rappsilber, J., & Helin, K. (2010) · Nature · doi:10.1038/nature08788 · Cited by 561
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E., & Imhof, A. (2005) · Nature Chemical Biology · doi:10.1038/nchembio721 · Cited by 521
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
Lehrman, G., Hogue, I. B., Palmer, S., Jennings, C., Spina, C. A., Wiegand, A., Landay, A. L., Coombs, R. W., Richman, D. D., Mellors, J. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67098-5 · Cited by 510
Self-citationJarid2 and PRC2, partners in regulating gene expression
Li, G., Margueron, R., Ku, M., Chambon, P., Bernstein, B. E., & Reinberg, D. (2010) · Genes & Development · doi:10.1101/gad.1886410 · Cited by 498
Antiretroviral therapy and management of HIV infection
Volberding, P. A., & Deeks, S. G. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60676-9 · Cited by 449
Dinoso, J. B., Kim, S. Y., Wiegand, A. M., Palmer, S. E., Gange, S. J., Cranmer, L., O'Shea, A., Callender, M., Spivak, A., Brennan, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903107106 · Cited by 441
NF‐κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation
Williams, S. A., Chen, L., Kwon, H., Ruiz‐Jarabo, C. M., Verdin, E., & Greene, W. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600900 · Cited by 430
Re-emergence of HIV after stopping therapy
Chun, T.-W., Davey, R. T., Engel, D., Lane, H. C., & Fauci, A. S. (1999) · Nature · doi:10.1038/44755 · Cited by 428
Kaneko, S., Li, G., Son, J., Xu, C.-F., Margueron, R., Neubert, T. A., & Reinberg, D. (2010) · Genes & Development · doi:10.1101/gad.1983810 · Cited by 398
Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
Kauder, S. E., Bosque, A., Lindqvist, A., Planelles, V., & Verdin, E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000495 · Cited by 374
Kanhere, A., Viiri, K., Araújo, C. C., Rasaiyaah, J., Bouwman, R. D., Whyte, W. A., Pereira, C. F., Brookes, E., Walker, K., Bell, G. W., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.019 · Cited by 370
Retroviral DNA integration: viral and cellular determinants of target-site selection
Lewinski, M. K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., Hannenhalli, S., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020060 · Cited by 364 · cited 1×
“Although most latent HIV-1 proviruses are found integrated into actively transcribed genes (28, 48), latent HIV-1 proviruses characteristically acquire heterochromatic structures.”
Fiskus, W., Wang, Y., Sreekumar, A., Buckley, K. M., Shi, H., Jillella, A., Ustun, C., Rao, R., Fernandez, P., Chen, J., et al. (2009) · Blood · doi:10.1182/blood-2009-03-213496 · Cited by 356
Recruitment of chromatin‐modifying enzymes by CTIP2 promotes HIV‐1 transcriptional silencing
Marban, C., Suzanne, S., Dequiedt, F., de Walque, S., Redel, L., Van Lint, C., Aunis, D., & Rohr, O. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601516 · Cited by 354
Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells
Bosque, A., & Planelles, V. (2009) · Blood · doi:10.1182/blood-2008-07-168393 · Cited by 340
Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
Archin, N. M., Espeseth, A., Parker, D., Cheema, M., Hazuda, D., & Margolis, D. M. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0191 · Cited by 336
Self-citationCpG Methylation Controls Reactivation of HIV from Latency
Blazkova, J., Trejbalova, K., Gondois-Rey, F., Halfon, P., Philibert, P., Guiguen, A., Verdin, E., Olive, D., Van Lint, C., Hejnar, J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000554 · Cited by 333
Han, Y., Lassen, K., Monie, D., Sedaghat, A. R., Shimoji, S., Liu, X., Pierson, T. C., Margolick, J. B., Siliciano, R. F., & Siliciano, J. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6122-6133.2004 · Cited by 327
Kinoshita, S., Su, L., Amano, M., Timmerman, L. A., Kaneshima, H., & Nolan, G. P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80326-x · Cited by 318
Chéné, I. D., Basyuk, E., Lin, Y., Triboulet, R., Knezevich, A., Chable‐Bessia, C., Mettling, C., Baillat, V., Reynes, J., Corbeau, P., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601517 · Cited by 312
Pearson, R., Kim, Y. K., Hokello, J., Lassen, K., Friedman, J., Tyagi, M., & Karn, J. (2008) · Journal of Virology · doi:10.1128/jvi.01383-08 · Cited by 297
Self-citationHIV rebounds from latently infected cells, rather than from continuing low-level replication
Joos, B., Fischer, M., Kuster, H., Pillai, S. K., Wong, J. K., Böni, J., Hirschel, B., Weber, R., Trkola, A., Günthard, H. F., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804192105 · Cited by 294
HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals
Trono, D., Van Lint, C., Rouzioux, C., Verdin, E., Barré-Sinoussi, F., Chun, T.-W., & Chomont, N. (2010) · Science · doi:10.1126/science.1191047 · Cited by 281
Chun, T.-W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26197 · Cited by 278
Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
Contreras, X., Schweneker, M., Chen, C.-S., McCune, J. M., Deeks, S. G., Martin, J., & Peterlin, B. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807898200 · Cited by 277
Ylisastigui, L., Archin, N. M., Lehrman, G., Bosch, R. J., & Margolis, D. M. (2004) · AIDS · doi:10.1097/00002030-200405210-00003 · Cited by 254
Self-citationLusic, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg631 · Cited by 249
Tyagi, M., Pearson, R. J., & Karn, J. (2010) · Journal of Virology · doi:10.1128/jvi.01519-09 · Cited by 249
Self-citationImai, K., Togami, H., & Okamoto, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.103531 · Cited by 248
Transcriptional Interference Antagonizes Proviral Gene Expression to Promote HIV Latency
Lenasi, T., Contreras, X., & Peterlin, B. M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.016 · Cited by 245
The Epigenetic Landscape of Latent Kaposi Sarcoma-Associated Herpesvirus Genomes
Günther, T., & Grundhoff, A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000935 · Cited by 242
Epigenetic Analysis of KSHV Latent and Lytic Genomes
Toth, Z., Maglinte, D. T., Lee, S. H., Lee, H.-R., Wong, L.-Y., Brulois, K. F., Lee, S., Buckley, J. D., Laird, P. W., Marquez, V. E., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001013 · Cited by 239
CBF‐1 promotes transcriptional silencing during the establishment of HIV‐1 latency
Tyagi, M., & Karn, J. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601928 · Cited by 220
Self-citationHan, Y., Lin, Y. B., An, W., Xu, J., Yang, H.-C., O'Connell, K., Dordai, D., Boeke, J. D., Siliciano, J. D., & Siliciano, R. F. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.06.008 · Cited by 215
Lu, F., Stedman, W., Yousef, M., Renne, R., & Lieberman, P. M. (2010) · Journal of Virology · doi:10.1128/jvi.01997-09 · Cited by 210
Cheng, A. S. L., Lau, S. S., Chen, Y., Kondo, Y., Li, M. S., Feng, H., Ching, A. K., Cheung, K. F., Wong, H. K., Tong, J. H., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3342 · Cited by 208
HMBA Releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and Activates HIV Transcription
Contreras, X., Barboric, M., Lenasi, T., & Peterlin, B. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030146 · Cited by 206
Karn, J. (2011) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328340ffbb · Cited by 184
Self-citationThe SWI/SNF Chromatin-remodeling Complex Is a Cofactor for Tat Transactivation of the HIV Promoter
Mahmoudi, T., Parra, M., Vries, R. G. J., Kauder, S. E., Verrijzer, C. P., Ott, M., & Verdin, E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603336200 · Cited by 182
Kwiatkowski, D. L., Thompson, H. W., & Bloom, D. C. (2009) · Journal of Virology · doi:10.1128/jvi.00686-09 · Cited by 171
Kutsch, O., Benveniste, E. N., Shaw, G. M., & Levy, D. N. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8776-8786.2002 · Cited by 168
Archin, N. M., Keedy, K. S., Espeseth, A., Dang, H., Hazuda, D. J., & Margolis, D. M. (2009) · AIDS · doi:10.1097/qad.0b013e32832ec1dc · Cited by 162
Self-citationPolycomb preferentially targets stalled promoters of coding and noncoding transcripts
Enderle, D., Beisel, C., Stadler, M. B., Gerstung, M., Athri, P., & Paro, R. (2011) · Genome Research · doi:10.1101/gr.114348.110 · Cited by 162
EZH2 and Histone 3 Trimethyl Lysine 27 Associated with Il4 and Il13 Gene Silencing in TH1 Cells
Koyanagi, M., Baguet, A., Martens, J. H. A., Margueron, R., Jenuwein, T., & Bix, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504766200 · Cited by 155
Brennan, T. P., Woods, J. O., Sedaghat, A. R., Siliciano, J. D., Siliciano, R. F., & Wilke, C. O. (2009) · Journal of Virology · doi:10.1128/jvi.02568-08 · Cited by 142
Williams, S. A., Kwon, H., Chen, L., & Greene, W. C. (2007) · Journal of Virology · doi:10.1128/jvi.02074-06 · Cited by 139
Kim, Y. K., Mbonye, U. R., Hokello, J., & Karn, J. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.054 · Cited by 136
Self-citationRecruitment of TFIIH to the HIV LTR is a rate‐limiting step in the emergence of HIV from latency
Kim, Y. K., Bourgeois, C. F., Pearson, R., Tyagi, M., West, M. J., Wong, J. Y., Wu, S.-Y., Chiang, C., & Karn, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601248 · Cited by 131
Self-citationEpigenetic regulation of HIV latency
Hakre, S., Chávez, L., Shirakawa, K., & Verdin, E. M. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283412384 · Cited by 125
p21WAF1 gene promoter is epigenetically silenced by CTIP2 and SUV39H1
Cherrier, T., Suzanne, S., Redel, L., Calao, M., Marban, C., Samah, B., Mukerjee, R., Schwartz, C., Gras, G. S., Sawaya, B. E., et al. (2009) · Oncogene · doi:10.1038/onc.2009.193 · Cited by 123
Mammalian Su(var) Genes in Chromatin Control
Fodor, B. D., Shukeir, N., Reuter, G., & Jenuwein, T. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113225 · Cited by 120
Tae, S., Karkhanis, V. A., VELASCO, K. R., Yaneva, M., Erdjument‐Bromage, H., Tempst, P., & Sif, S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr170 · Cited by 92
Mechanisms of HIV Latency: an Emerging Picture of Complexity
Margolis, D. M. (2010) · Current HIV/AIDS Reports · doi:10.1007/s11904-009-0033-9 · Cited by 91
Self-citationSewalt, R. G. A. B., Lachner, M., Vargas, M., Hamer, K. M., den Blaauwen, J. L., Hendrix, T., Melcher, M., Schweizer, D., Jenuwein, T., & Otte, A. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5539-5553.2002 · Cited by 91
Raaphorst, F. M., Otte, A. P., van Kemenade, F. J., Blokzijl, T., Fieret, E. J. H., Hamer, K. M., Satijn, D. P. E., & Meijer, C. J. L. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.5925 · Cited by 80
Subnetwork State Functions Define Dysregulated Subnetworks in Cancer
Chowdhury, S. A., Nibbe, R. K., Chance, M. R., & Koyutürk, M. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2010.0269 · Cited by 79
Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
Sun, F., Chan, E., Wu, Z., Yang, X., Márquez, V. E., & Yu, Q. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0479 · Cited by 69
Zhou, M., Deng, L., Lacoste, V., Park, H. U., Pumfery, A. M., Kashanchi, F., Brady, J. N., & Kumar, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13522-13533.2004 · Cited by 68
Yamaguchi, J., Sasaki, M., Sato, Y., Itatsu, K., Harada, K., Zen, Y., Ikeda, H., Nimura, Y., Nagino, M., & Nakanuma, Y. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01387.x · Cited by 60
Cited by
Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
Wagner, T. A., McLaughlin, S., Garg, K., Cheung, C. Y. K., Larsen, B. B., Styrchak, S., Huang, H. C., Edlefsen, P. T., Mullins, J. I., & Frenkel, L. M. (2014) · Science · doi:10.1126/science.1256304 · Cited by 677
Ex vivo analysis identifies effective HIV-1 latency–reversing drug combinations
Laird, G. M., Bullen, C. K., Rosenbloom, D. I. S., Martin, A. R., Hill, A. L., Durand, C. M., Siliciano, J. D., & Siliciano, R. F. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80142 · Cited by 391
HIV-1 transcription and latency: an update
Van Lint, C., Bouchat, S., & Marcello, A. (2013) · Retrovirology · doi:10.1186/1742-4690-10-67 · Cited by 338
Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
Kaminski, R., Chen, Y., Fischer, T., Tedaldi, E., Napoli, A., Zhang, Y., Karn, J., Hu, W., & Khalili, K. (2016) · Scientific Reports · doi:10.1038/srep22555 · Cited by 315
Self-citationBarriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
Katlama, C., Deeks, S. G., Autran, B., Martinez-Picado, J., van Lunzen, J., Rouzioux, C., Miller, M., Vella, S., Schmitz, J. E., Ahlers, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60104-x · Cited by 295
Metadata
- Authors
- Friedman, J., Cho, W.-K., Chu, C. K., Keedy, K. S., Archin, N. M., Margolis, D. M., & Karn, J.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2011-09
- Volume
- 85
- Issue
- 17
- Pages
- 9078-9089
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W1973694997
- Cited by
- 284
- References
- 81
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.